Johnson & Johnson (JNJ) DCF Valuation

Johnson & Johnson (JNJ) DCF Valuation

US | Healthcare | Drug Manufacturers - General | NYSE
Johnson & Johnson (JNJ) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Johnson & Johnson (JNJ) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

As an investor or analyst, this [Symbol] DCF Calculator is your essential resource for accurate valuation. Equipped with real data from Johnson & Johnson, you can adjust forecasts and instantly observe the effects.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 82,059.0 82,584.0 78,740.0 79,990.0 85,159.0 86,018.0 86,885.6 87,762.0 88,647.2 89,541.4
Revenue Growth, % 0 0.63978 -4.65 1.59 6.46 1.01 1.01 1.01 1.01 1.01
EBITDA 28,272.0 27,498.0 30,925.0 27,170.0 23,725.0 29,048.5 29,341.5 29,637.5 29,936.4 30,238.4
EBITDA, % 34.45 33.3 39.27 33.97 27.86 33.77 33.77 33.77 33.77 33.77
Depreciation 7,009.0 7,231.0 7,390.0 6,970.0 7,486.0 7,601.7 7,678.4 7,755.9 7,834.1 7,913.1
Depreciation, % 8.54 8.76 9.39 8.71 8.79 8.84 8.84 8.84 8.84 8.84
EBIT 21,263.0 20,267.0 23,535.0 20,200.0 16,239.0 21,446.8 21,663.1 21,881.6 22,102.3 22,325.3
EBIT, % 25.91 24.54 29.89 25.25 19.07 24.93 24.93 24.93 24.93 24.93
Total Cash 19,287.0 25,185.0 31,608.0 22,281.0 22,927.0 25,619.5 25,877.9 26,139.0 26,402.6 26,668.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 14,481.0 13,576.0 15,283.0 14,039.0 14,873.0
Account Receivables, % 17.65 16.44 19.41 17.55 17.46
Inventories 9,020.0 9,344.0 10,387.0 10,268.0 11,181.0 10,574.1 10,680.7 10,788.5 10,897.3 11,007.2
Inventories, % 10.99 11.31 13.19 12.84 13.13 12.29 12.29 12.29 12.29 12.29
Accounts Payable 8,544.0 9,505.0 11,055.0 9,889.0 9,632.0 10,259.3 10,362.8 10,467.3 10,572.9 10,679.6
Accounts Payable, % 10.41 11.51 14.04 12.36 11.31 11.93 11.93 11.93 11.93 11.93
Capital Expenditure -3,498.0 -3,347.0 -3,652.0 -4,009.0 -4,543.0 -4,008.5 -4,048.9 -4,089.8 -4,131.0 -4,172.7
Capital Expenditure, % -4.26 -4.05 -4.64 -5.01 -5.33 -4.66 -4.66 -4.66 -4.66 -4.66
Tax Rate, % -133.39 -133.39 -133.39 -133.39 -133.39 -133.39 -133.39 -133.39 -133.39 -133.39
EBITAT 18,552.4 18,076.5 25,621.2 18,720.4 37,900.0 20,122.2 20,325.2 20,530.2 20,737.3 20,946.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 7,106.4 23,502.5 28,159.2 21,878.4 38,839.0 24,595.6 23,797.9 24,037.9 24,280.4 24,525.3
WACC, % 6.67 6.68 6.72 6.69 6.72 6.7 6.7 6.7 6.7 6.7
PV UFCF
SUM PV UFCF 100,219.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 25,016
Terminal Value 532,719
Present Terminal Value 385,265
Enterprise Value 485,485
Net Debt 7,473
Equity Value 478,012
Diluted Shares Outstanding, MM 2,560
Equity Value Per Share 186.69

What You Will Get

  • Real JNJ Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Evaluate various scenarios to forecast Johnson & Johnson’s future performance.
  • User-Friendly Design: Designed for professionals while remaining approachable for newcomers.

Key Features

  • 🔍 Real-Life JNJ Financials: Pre-filled historical and projected data for Johnson & Johnson (JNJ).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Johnson & Johnson’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Johnson & Johnson’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Step 1: Download the prebuilt Excel template with Johnson & Johnson's (JNJ) data included.
  • Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
  • Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view recalculated results, including Johnson & Johnson's (JNJ) intrinsic value.
  • Step 5: Make informed investment decisions or generate reports based on the outputs.

Why Choose Johnson & Johnson (JNJ)?

  • Proven Track Record: A history of consistent performance and innovation in healthcare.
  • Commitment to Quality: High standards in product safety and efficacy ensure customer trust.
  • Diverse Portfolio: A wide range of products across pharmaceuticals, medical devices, and consumer health.
  • Global Reach: Operations in over 60 countries, providing access to a vast market.
  • Ethical Practices: Strong focus on sustainability and corporate responsibility.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessments on Johnson & Johnson (JNJ).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform internal decision-making processes.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in Johnson & Johnson (JNJ) stock.
  • Students and Educators: Utilize real-world data to enhance financial modeling skills and education.
  • Health Sector Enthusiasts: Gain insights into how healthcare companies like Johnson & Johnson (JNJ) are valued in the marketplace.

What the Template Contains

  • Pre-Filled DCF Model: Johnson & Johnson’s financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Johnson & Johnson’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

No products were found matching.